Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition
Histone deacetylase (HDAC) inhibition improves function and extends survival in rodent models of a host of neurological conditions, including stroke, and neurodegenerative diseases. Our understanding, however, of the contribution of individual HDAC isoforms to neuronal death is limited. In this stud...
Saved in:
| Main Author: | Sleiman, Sama F. (author) |
|---|---|
| Format: | article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/10725/6132 https://doi.org/10.1523/JNEUROSCI.1010-14.2014 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://www.jneurosci.org/content/34/43/14328.short |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lactic acid is a novel antidepressant that mediates its effects by modulating the levels and activity of histone deacetylases (HDAC). (c2018)
by: Karnib, Nabil H.
Published: (2018) -
Histone deacetylase inhibitors and mithramycin a impact a similar neuroprotective pathway at a crossroad between cancer and neurodegeneration
by: Sleiman, Sama F.
Published: (2011) -
Lactic acid mediates resistance to stress through class I HDAC induction in a chronic social defeat model of depression. (c2017)
by: Ghandour, Rim Mohamad El
Published: (2017) -
Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro
by: Najem, Sonia A.
Published: (2019) -
Proteomics Analysis of Human Obesity Reveals the Epigenetic Factor HDAC4 as a Potential Target for Obesity
by: Mohamed Abu-Farha (18535590)
Published: (2013)